NAPSRX PRACTICE QUESTIONS- TEST PREP

1. Pharmaceuticals are arguably the most socially important healthcare product. A. TRUE B. FALSE 2. Pharmaceutical development is a high-risk undertaking, in which many promising leads prove disappointing. . TRUE A. FALSE 3. Pharmaceutical sales are highest in which geographical regions? . The U.S., Saudi Arabia, and Japan A. The U.S., Western Europe, and Japan B. Western Europe, Australia, and Canada C. Western Europe, Canada, and Saudi Arabia 4. The U.S. accounts for about ____ of the world’s pharmaceutical revenues. . 30% A. 50% B. 80% C. 95% 5. Which of the following has fueled recent growth in the pharmaceutical industry? . increased international standardization and regulation A. international legalization of DTC advertising B. population growth and increased life expectancies C. all of these 6. According to your manual, which statement accurately describes the predicted relationship between pharmaceutical companies and genomic research facilities? . "Genomic research company" is another term for "ethical research company." A. Partnerships between pharmaceutical companies and genomic companies will not prove immediately profitable. B. Pharmaceutical companies have little to no interest in partnerships with genomic research companies. C. Pharmaceutical companies will be genomic research companies' biggest competitors in the coming years. 7. Prescription drug therapy is not cost-effective for insurance companies and healthcare providers. . TRUE A. FALSE 8. The high price of healthcare is explained by the high price of medicines. . TRUE